If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOnward Opps Regulatory News (ONWD)

Share Price Information for Onward Opps (ONWD)

Share Price is delayed by 15 minutes
Get Live Data
124.00    -0.50 (-0.40%)
Bid:
122.00
Ask:
126.00
Spread: 4.00 (3.279%)
Market Cap: £41.91m
ONWD Live PriceLast checked at - London Stock Exchange

Intraday Onward Opps Share Chart

Additional Subscription and Total Voting Rights

26 Sep 2024 15:27

RNS Number : 8666F
Onward Opportunities Limited
26 September 2024
 

26 September 2024

 

Onward Opportunities Limited

("Onward Opportunities" or the "Company")

 

Additional Subscription and Total Voting Rights

 

Onward Opportunities Limited, the UK smaller company focussed investment company, is pleased to announce that, further to the announcement of 26 September 2024, in response to investor demand it has raised additional gross proceeds of an aggregate of approximately £0.15 million by way of an additional direct subscription with the Company for an aggregate of 118,110 new ordinary shares (the "Additional Subscription Shares") at a price of 127.0 pence per Additional Subscription Share.

 

Pursuant to the Additional Subscription, application has been made for all Subscription Shares to be admitted to trading on AIM ("Admission"). Admission is expected to occur at 8.00 a.m. on or around 1 October 2024 and the Subscription Shares will, on issue, rank pari passu in all respects with the Company's existing ordinary shares.

 

Total Voting Rights

 

On Admission, the Company will have a total of 21,555,594 ordinary shares in issue. No ordinary shares are held in treasury. The figure of 21,555,594 may be used by the Company's shareholders as the denominator in the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Capitalised terms used but not otherwise defined in this announcement shall have the meanings set out in the Company's earlier announcement of the Subscription on 26 September 2024.

 

FOR FURTHER ENQUIRIES:

 

Onward Opportunities Limited

Andrew Henton, Chairman

 

Tel: +44 (0)20 3416 9143

hello@dowgate.co.uk

Dowgate Wealth Limited (Portfolio Manager)

Laurence Hulse, Investment Director

 

Tel: +44 (0)20 3416 9143

hello@dowgate.co.uk

Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)

Ben Jeynes / Camilla Hume / Dan Hodkinson / Hamish Waller (Corporate Finance)

Chris West / Charlie Combe (Sales and ECM)

 

Tel: +44 (0) 207 220 0500

Dowgate Capital Limited (Joint Broker)

Russell Cook / Nicholas Chambers

 

Tel: +44 (0)20 3903 7715

 

To find out more, please visit: www.onwardopportunities.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEZZGZLDVKGDZM
Date   Source Headline
2nd Jan 20255:50 pmRNSNet Asset Value(s)
6th Dec 20247:00 amRNSAdditional Subscription and Total Voting Rights
4th Dec 20247:00 amRNSIssue of Equity
2nd Dec 20245:38 pmRNSNet Asset Value(s)
1st Nov 20244:42 pmRNSNet Asset Value(s)
30th Oct 20244:40 pmRNSHolding(s) in Company
24th Oct 202412:00 pmRNSIssue of Equity
11th Oct 20247:00 amRNSPublication of Q3 2024 Factsheet
3rd Oct 20243:44 pmRNSHolding(s) in Company
2nd Oct 20244:34 pmRNSNet Asset Value(s)
26th Sep 20243:27 pmRNSAdditional Subscription and Total Voting Rights
26th Sep 20247:00 amRNSIssue of Equity
6th Sep 20247:00 amRNSHalf-year Report
3rd Sep 20244:21 pmRNSNet Asset Value
2nd Aug 20242:16 pmRNSNet Asset Value(s)
19th Jul 20242:31 pmRNSAcquisition of Interest in The Mission Group plc
11th Jul 20247:00 amRNSHalf-Year Update
4th Jul 20247:00 amRNSNet Asset Value(s)
3rd Jul 20247:00 amRNSIssue of Equity
11th Jun 20249:06 amRNSResult of AGM
4th Jun 20247:00 amRNSNet Asset Value(s)
8th May 20247:00 amRNSPosting of Annual Report and Notice of AGM
7th May 20247:00 amRNSNet Asset Value(s)
26th Apr 20247:00 amRNSIssue of Equity/Director/PDMR Shareholding
11th Apr 20247:00 amRNSAnnual Results
3rd Apr 20247:00 amRNSNet Asset Value(s)
28th Mar 20244:51 pmRNSHolding(s) in Company
26th Mar 20247:00 amRNSIssue of Equity
5th Mar 20243:21 pmRNSNet Asset Value(s)
22nd Feb 20242:20 pmRNSDirector/PDMR Shareholding
2nd Feb 20247:00 amRNSNet Asset Value(s)
18th Jan 202410:44 amRNSHolding(s) in Company
10th Jan 20247:00 amRNSQuarterly Factsheet – Q4 2023
10th Jan 20247:00 amRNSPortfolio Update
4th Jan 20247:00 amRNSNet Asset Value(s)
18th Dec 202311:26 amRNSHolding(s) in Company
4th Dec 20233:19 pmRNSNet Asset Value(s)
3rd Nov 20233:14 pmRNSNet Asset Value(s)
31st Oct 202312:00 pmRNSTVR & Change of Nominated Adviser and Joint Broker
24th Oct 20237:00 amRNSQuarterly Factsheet - Q3 2023
11th Oct 20235:39 pmRNSHolding(s) in Company
9th Oct 20235:06 pmRNSHolding(s) in Company
5th Oct 20232:54 pmRNSNet Asset Value(s)
4th Oct 20237:00 amRNSIssue of Equity
4th Sep 20237:00 amRNSNet Asset Value(s)
4th Sep 20237:00 amRNSHalf-year Report
3rd Aug 20232:08 pmRNSNet Asset Value(s)
14th Jul 20237:00 amRNSQuarterly Factsheet – Q2 2023
5th Jul 20232:21 pmRNSNet Asset Value(s)
5th Jun 20235:36 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.